Brain Structure Relations With Psychopathology Trajectories in the ABCD Study - 27/07/23
, Boyu Ren, PhD a, d, Diego A. Pizzagalli, PhD a, b, cAbstract |
Objective |
A general psychopathology (p) factor captures shared variation across mental disorders. Structural neural alterations have been associated with the p factor concurrently, but less is known about whether these alterations relate to within-person change in the p factor over time, especially during preadolescence, a period of neurodevelopmental changes.
Method |
This study examined whether baseline brain structure was prospectively related to the trajectory of the p factor and specific forms of psychopathology over 2 years in 9,220 preadolescents (aged 9-10 at baseline) from the Adolescent Brain Cognitive Development Study (ABCD). Longitudinal multilevel models were conducted to determine whether baseline brain structure (volume, surface area, thickness) was associated with between-person differences and within-person change in the p factor (from a higher-order confirmatory factor model) and internalizing, externalizing, neurodevelopmental, somatization, and detachment factor scores (from a correlated factors model) over 3 study waves.
Results |
Smaller global volume and surface area, but not thickness, were associated with higher between-person levels of the p factor scores, which persisted over time. None of the brain structure measures were related to within-person change in the p factor scores. Lower baseline cortical thickness was associated with steeper decreases in internalizing psychopathology, which was driven by lower thickness within sensorimotor and temporal regions.
Conclusion |
These novel results identify specific brain structure features that might contribute to transdiagnostic psychopathology development in preadolescence. Children with smaller total brain volume and surface area may be vulnerable to persistent general psychopathology during preadolescence. Cortical thinning reflective of pruning and myelination in sensorimotor and temporal brain regions specifically may protect against increases in internalizing, but not general psychopathology, during preadolescence.
Le texte complet de cet article est disponible en PDF.Key words : brain structure, general psychopathology, longitudinal, p factor, transdiagnostic
Plan
| Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development (ABCD) Study (abcdstudy.org), held in the National Institute of Mental Health Data Archive (NDA). This is a multisite, longitudinal study designed to recruit more than 10,000 children aged 9-10 and follow them over 10 years into early adulthood. The ABCD Study is supported by the National Institutes of Health (NIH) and additional federal partners under award numbers U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041123, and U24DA041147. A full list of supporters is available at federal-partners.html. A listing of participating sites and a complete listing of the study investigators can be found at consortium_members/. ABCD Consortium investigators designed and implemented the study and/or provided data but did not necessarily participate in analysis or writing of this report. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD Consortium investigators. The ABCD data repository grows and changes over time. The ABCD data used in this report came from DOI 10.15154/1524711. DOIs can be found at 1524711. The authors received funding support from the NIH: Dr. Romer (grant F32 MH124409); Dr. Ren (grants 5R01 AG066670-02, 5R01 MH120400-03, 1R01 AT011002-01A1, 1R01 MH125852, 3R01 HD093680-04S1, and 5R33 DA042847-05); and Dr. Pizzagalli (grants R01 MH101521 and R37 MH068376). |
|
| Dr. Ren served as the statistical expert for this research. |
|
| Author Contributions Conceptualization: Romer Data curation: Romer Formal analysis: Romer, Ren Resources: Pizzagalli Supervision: Pizzagalli Visualization: Romer Writing – original draft: Romer Writing – review and editing: Ren, Pizzagalli |
|
| Disclosure: Dr. Pizzagalli has received consulting fees from Albright Stonebridge Group, Boehringer Ingelheim, Compass Pathways, Concert Pharmaceuticals, Engrail Therapeutics, Neumora Therapeutics (former BlackThorn Therapeutics), Neurocrine Biosciences, Neuroscience Software, Otsuka Pharmaceuticals, Sunovion Pharmaceuticals, and Takeda Pharmaceuticals; honoraria from the Psychonomic Society and the American Psychological Association (for editorial work) and Alkermes, and research funding from National Institute of Mental Health, Dana Foundation, Brain and Behavior Research Foundation, Millennium Pharmaceuticals, and Wellcome Leap. He has received stock options from Compass Pathways, Engrail Therapeutics, Neumora Therapeutics (former BlackThorn Therapeutics), and Neuroscience Software over the past 3 years. Drs. Romer and Ren have confirmed they have no disclosures to make in association with the work presented in this manuscript, and there are no conflicts of interest with the work conducted in this study. All views expressed are solely those of the authors. |
Vol 62 - N° 8
P. 895-907 - août 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
